D.E. Shaw & Co’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.89M Buy
341,540
+77,117
+29% +$653K ﹤0.01% 1713
2025
Q1
$2.13M Buy
264,423
+131,090
+98% +$1.05M ﹤0.01% 1812
2024
Q4
$1.2M Buy
133,333
+39,384
+42% +$354K ﹤0.01% 2057
2024
Q3
$689K Buy
93,949
+8,055
+9% +$59K ﹤0.01% 2334
2024
Q2
$490K Buy
85,894
+4,152
+5% +$23.7K ﹤0.01% 2497
2024
Q1
$410K Sell
81,742
-10,820
-12% -$54.2K ﹤0.01% 2485
2023
Q4
$832K Sell
92,562
-264,584
-74% -$2.38M ﹤0.01% 2157
2023
Q3
$2.78M Sell
357,146
-256,367
-42% -$1.99M ﹤0.01% 1535
2023
Q2
$5.94M Buy
613,513
+108,259
+21% +$1.05M 0.01% 1170
2023
Q1
$5.54M Buy
505,254
+398,970
+375% +$4.37M 0.01% 1273
2022
Q4
$459K Buy
106,284
+6,447
+6% +$27.9K ﹤0.01% 2747
2022
Q3
$751K Sell
99,837
-13,723
-12% -$103K ﹤0.01% 2688
2022
Q2
$1.14M Buy
113,560
+34,647
+44% +$348K ﹤0.01% 2624
2022
Q1
$977K Sell
78,913
-109,420
-58% -$1.35M ﹤0.01% 2888
2021
Q4
$4.31M Sell
188,333
-145,536
-44% -$3.33M ﹤0.01% 1804
2021
Q3
$7.39M Buy
333,869
+294,258
+743% +$6.51M 0.01% 1215
2021
Q2
$513K Buy
39,611
+27,776
+235% +$360K ﹤0.01% 2880
2021
Q1
$154K Sell
11,835
-289,198
-96% -$3.76M ﹤0.01% 2830
2020
Q4
$4.16M Sell
301,033
-38,006
-11% -$525K ﹤0.01% 1400
2020
Q3
$4.99M Buy
339,039
+222,073
+190% +$3.27M 0.01% 1192
2020
Q2
$1.9M Sell
116,966
-5,672
-5% -$92.1K ﹤0.01% 1634
2020
Q1
$1.78M Buy
+122,638
New +$1.78M ﹤0.01% 1570
2019
Q4
Sell
-335,027
Closed -$1.79M 2630
2019
Q3
$1.79M Sell
335,027
-58,273
-15% -$311K ﹤0.01% 1621
2019
Q2
$2.59M Sell
393,300
-154,898
-28% -$1.02M ﹤0.01% 1500
2019
Q1
$3.56M Buy
548,198
+159,387
+41% +$1.04M ﹤0.01% 1310
2018
Q4
$2.65M Buy
388,811
+124,940
+47% +$852K ﹤0.01% 1386
2018
Q3
$1.75M Buy
263,871
+148,399
+129% +$985K ﹤0.01% 1587
2018
Q2
$650K Sell
115,472
-117,161
-50% -$660K ﹤0.01% 2055
2018
Q1
$1.21M Buy
+232,633
New +$1.21M ﹤0.01% 1726